May We Strengthen the Human Natural Defenses with Bacterial Lysates?

World Allergy Organization Journal

Volumn 3, Issue , 2010, Pages S17-S23

  Villa, Elisa ^a   Garelli, Valentina ^a   Braido, Fulvio ^a   Melioli, Giovanni ^b   Canonica, Giorgio Walter ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

airways infection; bacterial lysates; immunology

Indexed keywords

BACTERIUM LYSATE; OM 85BV; PLACEBO;

ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; DRUG EFFECT; DRUG USE; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA; KLEBSIELLA OZAENAE; KLEBSIELLA PNEUMONIAE; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; SYSTEMATIC REVIEW; TREND STUDY;

EID: 79960354234     PISSN: None     EISSN: 19394551     Source Type: Journal    
DOI: 10.1186/1939-4551-3-S2-S17     Document Type: Article

References (54)

1. File, T.M., The epidemiology of respiratory tract infections. Semin Respir Infect 15 (2000), 184–194.
2. Rozy, A., Chorostowska-Wynimko, J., Bacterial immunostimulants-mechanism of action and clinical application in respiratory diseases. Pneumonol Alergol Pol 76 (2008), 353–359.
3. Collet, J.P., Shapiro, P., Ernst, P., Renzi, T., Ducruet, T., Robinson, A., effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156 (1997), 1719–1724.
4. Steurer-Stey, C., Bachmann, L.M., Steurer, J., TramȲr, M.R., Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review. Chest 126 (2004), 1645–1655.
5. Schaad, U.B., Mɒtterlein, R., Goffin, H., BV-Child Study Group. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest 122 (2002), 2042–2049.
6. Rossi, G.A., Peri, C., Raynal, M.E., Defilippi, A.C., Risso, F.M., Schenone, G., Pallestrini, E., Melioli, G., Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels. Immunol Lett 86 (2003), 85–91.
7. Pauwels, R., Buist, A., Calverley, P., Jenkins, C., Hurd, S.S., GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 163 (2001), 1256–1276.
8. Murphy, T., Sethi, S., State of the Art. Bacterial infection in chronic obstructive pulmonary disease. Ann Rev Respir Dis 146 (1992), 1067–1083.
9. Braido, F., Tarantini, F., Ghiglione, V., Melioli, G., Canonica, G.W., Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections. Int J Chron Obstruct Pulmon Dis 2 (2007), 335–345.
10. Singh K, Amdekar S, Singh DD, Tripathi P, Sharma GL, Yadav H. Innate and specific gut-associated immunity and microbial interference. FEMS Immunol Med Microbiol. 2009;55:6 –12. Epub 2008 Dec 10. Review.
11. Brandtzaeg, P., Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 70 (2009), 505–515.
12. Kang, Y., Tan, L., Carroll, M., Gentle, M., Sim, R.B., Target pattern recognition by complement proteins of the classical and alternative pathways. Adv Exp Med Biol 653 (2009), 117–128.
13. Ju, X., Clark, G., Hart, D.N., Review of human DC subtypes. Methods Mol Biol 595 (2010), 3–20.
14. Kabelitz D, SchrɆder J-M, (eds): Mechanisms of Epithelial Defense. Chem Immunol Allergy. Basel, Karger. 2005, 86: I-XII. Copyright 2005 by S. Karger AG, Basel (Swiss).
15. Fuggetta, M., Lanzilli, G., Attivazione delle risposte immunitarie mediante vaccini batterici. Eur Respir News 15 (2007), 69–77.
16. Lanzilli, G., Falchetti, R., Tricarico, M., Ungheri, D., Fuggetta, M.P., In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. Int J Immunopathol Pharmacol 18 (2005), 245–254.
17. Lanzilli, G., Falchetti, R., Cottarelli, A., Macchi, A., Ungheri, D., Fuggetta, M.P., In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes. Int J Immunopathol Pharmacol 19 (2006), 551–559.
18. Braido, F., Tarantini, F., Ghiglione, V., Melioli, G., Canonica, G.W., Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections. Int J Chron Obstruct Pulmon Dis 2 (2007), 335–345.
19. Chiavaroli, C., Moore, A., An hypothesis to link the opposing immunological effects induced by the bacterial lysate OM-89 in urinary tract infection and rheumatoid arthritis. BioDrugs 20 (2006), 141–149.
20. Alyanakian, M-A, Grela, F., Aumeunier, A., Transforming growth factor-ȣ and natural killer T-cells are involved in the protective effect of a bacterial extract on Type 1 diabetes. Diabetes 55 (2006), 179–185.
21. Ziuzio, S., Sakson, B., Vaccine therapy in the treatment of nasal and sinus bacterial allergies. Wiad Lek 47 (1994), 510–513.
22. Banche, G., Allizond, V., Mandras, N., Garzaro, M., Cavallo, G., et al. Improvement of clinical response in allergic rhinitis patients treated with an oral immunostimulating bacterial lysate: in vivo immunological effects. Int J Immunopathol Pharmacol 20 (2007), 129–138.
23. Heintz, B., Schlenter, W.W., Kirsten, R., Nelson, K., Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis-a multi-centric, placebo-controlled, double-blind study. Int J Clin Pharmacol Ther Toxicol 27 (1989), 530–534.
24. Dughera, L., Serra, A.M., Battaglia, E., Tibaudi, D., Navino, M., Emanuelli, G., Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension. Minerva Gastroenterol Dietol 50 (2004), 149–153.
25. Bi-Feng Qian Tonkonogy, S.L., Hoentjen, F., Dieleman, L., Balfour Sartor, R., Dysregulated luminal bacterial antigen-specific T-cell responses and antigen-presenting cell function in HLA-B27 transgenic rats with chronic colitis. Immunology 116 (2005), 112–121.
26. Kullberg, M., Andersen, J., Gorelick, P.L., Caspar, P., Suerbaum, S., et al. Induction of colitis by a CD4+ T cell clone specific for a bacterial epitope. Proc Natl Acad Sci USA 100 (2003), 15830–15835.
27. Hoentjen, F., Welling, G., Harmsen, H.J., Zhang, X., Snart, J., et al. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis 11 (2005), 977–985.
28. Marinova, S., Nenkov, P., Markova, R., Nikolaeva, S., Kostadinova, R., Mitov, I., Vretenarska, M., Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections. Int J Immunopathol Pharmacol 18 (2005), 457–473.
29. Neumann, C., ZɆnnchen, B., Willershausen-ZɆnnchen, B., The efficacy of an oral immunostimulant in treating periodontitis: a pilot study. Eur J Med Res 1 (1996), 387–392.
30. Oehling, A., Baena-Cagnani, C., Neffen, H., Bacterial Immunotherapy of childhood bronchial asthma. Allergol Immunopathol (Madr) 8 (1980), 177–184.
31. Sramek, J., Josifko, M., Helcl, J., Holoubkovȥ, E., Janout, V., Kozesnȷk, B., Macȥovȥ, I., Bacterial lysate (I.R.S. 19) applied intranasally in the prevention of acute respiratory diseases in children: a randomized double-blind study. J Hyg Epidemiol Microbiol Immunol 30 (1986), 377–385.
32. Zagar, S., Lofler-Badzek, D., Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trial. ORL J Otorhinolaryngol Relat Spec 50 (1989), 397–404.
33. Collet, J.P., Ducruet, T., Kramer, M.S., Haggerty, J., Floret, D., Chomel, J., Durr, F., Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicreche Research Group. Pediatr Infect Dis J 12 (1993), 648–652.
34. Gomez Barreto, D., De la Torre, C., Alvarez, A., Faure, A., Berber, A., Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children. Allergol Immunopathol (Madr) 26 (1998), 17–22.
35. Ruah, S.B., Ruah, C., van Aubel, A., Abel, S., Elsasser, U., Efficacy of a polyvalent bacterial lysate in children with recurrent respiratory tract infections. Adv Ther 18 (2001), 151–162.
36. Gutierrez-Tarango, M., Berber, A., Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. Chest 119 (2001), 1742–1748.
37. Schaad, U.B., Mutterlein, R., Goffin, H., BV-Child Study Group. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest 122 (2002), 2042–2049.
38. Rosaschino, F., Cattaneo, L., Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered polyvalent mechanical bacterial lysates (PMBL). Acta Biomed Ateneo Parmense 75 (2004), 171–178.
39. Del-Rio-Navarro, B., Luis Sienra-Monge, J.J., Berber, A., Torres-Alcȥntara, S., Avila-CastaɁɃn, L., GɃmez-Barreto, D., Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels. Allergol Immunopathol (Madr) 31 (2003), 7–13.
40. Heintz, B., Schlenter, W.W., Kirsten, R., Nelson, K., Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis: a multi-centric, placebo-controlled, double-blind study. Int J Clin Pharmacol Ther Toxicol 27 (1989), 530–534.
41. Orcel B, Delclaux B, Baud M, Derenne JP: Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. Eur Respir J. 7: 446-452.
42. Cvoriscec, B., Ustar, M., Pardon, R., Palecek, I., Stipic-Markovic, A., Zimic, B., Oral immunotherapy of chronic bronchitis: a double-blind placebo-controlled multicentre study. Respiration 55 (1989), 129–135.
43. Macchi, A., Vecchia, L.D., Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections. Arzneimittelforschung 55 (2005), 276–281.
44. Tricarico, D., Varricchio, A., D'Ambrosio, S., Ascione, E., Motta, G., Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial. Arzneimittelforschung 54 (2004), 57–63.
45. Mora, R., Barbieri, M., Passali, G.C., Sovatzis, A., Mora, F., Cordone, M.P., A preventive measure for otitis media in children with upper respiratory tract infections. Int J Pediatr Otorhinolaryngol 63 (2002), 111–118.
46. Ball, P., Tillotson, G., Wilson, R., Chemotherapy for chronic bronchitis. Controversies. Presse Med 24 (1995), 189–194.
47. Nicotra, M., Kronenberg, R.S., Con: antibiotic use in exacerbations of chronic bronchitis. Semin Respir Infect 8 (1993), 254–258.
48. Isada, C.M., Pro: antibiotics for chronic bronchitis with exacerbations. Semin Respir Infect 8 (1993), 243–253.
49. Debbas, N., Derenne, J.P., Preventive effects of an immunostimulating product on recurrent infections of chronic bronchitis in the elderly. Lung 168:Suppl (1990), 737–740.
50. Collet, J.P., Shapiro, P., Ernst, P., Renzi, T., Ducruet, T., Robinson, A., Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med 156 (1997), 1719–1724.
51. Li, J., Zheng, J., Yuan, J., Zeng, G., Zhong, N., Lin, C.Y., Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease. Chin Med J (Engl) 117 (2004), 828–834.
52. Steurer-Stey, C., Bachmann, L., Steurer. Tramȳr, M.R., Oral purified bacterial extracts inchronic bronchitis and COPD: systematic Review. Chest 126 (2004), 1645–1655.
53. Cazzola, M., A new bacterial lysate protects by reducing infectious exacerbations in moderate to very severe COPD A double-blind, randomized, placebo controlled trial. Trends in Med 6 (2006), 191–199.
54. Cazzola, M., Noschese, P., Di Perna, F., Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone. Therapeutics Advances in Respiratory Diseases 3:2 (2009), 59–63.